Plastic, reconstructive and aesthetic surgery (PRAS) is a significant yet often overlooked specialty in medical school curricula. The impact of social media and unregulated information sources can distort the perceptions of medical specialties, including PRAS, leading to a decline in student interest, inappropriate referrals and strain on healthcare services. This systematic review aimed to understand the perceptions of medical students towards PRAS, identify influencing factors and explore strategies to address these influences. The review followed the PRISMA 2020 guidelines. Four databases were searched, and the inclusion and exclusion criteria were applied. Data from 17 relevant studies were analysed in Microsoft Excel using descriptive statistics. The risk of bias was assessed using a modified Newcastle–Ottawa Scale. Medical students generally held positive perceptions about PRAS, particularly regarding career opportunities, specialised skills and the nature of the specialty. However, their awareness of the full scope of plastic surgery is limited, with a focus on cosmetic and aesthetic procedures. Social media and the internet significantly influenced the students' perceptions, whereas personal experiences had a minor impact. Education and training in plastic surgery positively affected the students' perceptions. Nevertheless, there is a need for improved representation of PRAS in medical school curricula and promotion of accurate information through reliable sources. Students exhibited a favourable attitude towards plastic surgery, but their knowledge of the specialty can be enhanced. Strengthening PRAS teaching in medical schools and ensuring accurate information dissemination can foster a deeper understanding and interest in this field. Large-scale studies with standardised protocols should be conducted in different countries to gain comprehensive insights tailored to specific educational contexts.

Context: Primary central nervous system tumours have poor survival outcomes. Surgery, the first-line treatment, presents technical limitations, such as visualising the whole tumour border. Intracranial impedance monitoring and electrocorticography techniques provide insights into the local field potential characteristics, resistance and capacitance properties of brain tissue. We hypothesised that measurements obtained by either modality can distinguish between tumour and healthy brain tissue intraoperatively. Methods: A “Preferred Reporting Items for Systematic Reviews and Meta-Analyses” (PRISMA)-compliant systematic review was conducted, searching PubMed, Ovid, Scopus, Cochrane and Web of Science. Studies on electrocorticography and impedance monitoring in patients with brain tumours were included. Data on patient demographics, technical details, obtained results and safety were extracted and analysed in Excel. Results: Eighteen studies involving 286 patients in total were identified. Ten impedance studies showed that brain tumour tissue has significantly different values than healthy tissue, while its resistivity varies, being either higher or lower. Eight electrocorticography studies indicated increased high gamma power and altered connectivity in tumour tissue. No studies integrated impedance monitoring and electrocorticography in one device. Conclusion: Impedance and electrocorticography measurements have the potential of differentiating between tumour and unaffected issues intra-operatively. Larger studies with standardised protocols are needed to validate these findings. Additionally, the combination of these two modalities has the potential for improved specificity with a single device. Future research should explore the role of these modalities in enhancing tumour margin identification across different tumour subtypes and in improving survival outcomes.

BACKGROUND AND OBJECTIVES: Lumbar drain (LD) insertion is a common cerebrospinal fluid (CSF) diversion method in neurosurgery; however, infection remains a major complication with significant morbidity. We evaluated the incidence, etiology, and associated risk factors of LD infection across 4 neurosurgical units over 15 years. METHODS: This retrospective multicenter cohort study included all adults requiring a LD between January 2009 and February 2024. Demographic, clinical, and microbiological characteristics were analyzed. LD infections were defined by positive CSF cultures and clinical symptoms. Risk factors were assessed by multivariate logistic regression analysis using IBM SPSS®. RESULTS: A total of 1017 patients required a LD, and the overall infection rate was 11.4% (116 infections). Significant risk factors for LD infection identified by univariate analysis were preoperative use of oral steroids ( P < .001), previous CSF drainage ( P = .019), LD insertion for 2 or more days ( P = .001), out-of-hours surgery ( P = .008), and CSF leak at the operation site ( P = .007). Conversely, factors reducing the risk of infection were LD insertion during the primary surgery ( P = .015) and the reason for insertion ( P = .029). Multivariate analysis confirmed increased incidence of LD infection with oral steroid use ( P = .01), LD insertion >7 days after the primary surgery ( P = .019), no previous CSF drainage ( P = .029), LD removal ≥2 days ( P = .002), out-of-hours primary surgery ( P = .024), CSF leak from the LD puncture site >2 days after LD insertion ( P = .074), LD disconnection >3 days postinsertion ( P = .028), and bleeding from the LD puncture site >2 days after drain insertion ( P = .026). CONCLUSION: We report a large patient series evaluating the factors associated with LD infections across multiple neurosurgical subspecialties. To reduce infection risk, LDs should be inserted during primary surgery, kept for the shortest duration, and promptly removed if disconnected, avoiding unnecessary sampling.

Managing post-traumatic critical bone defects in the tibia remains challenging. Vascularised free fibula grafts (VFFG) are an attractive option due to their versatility and ability to integrate with host bone. However, they are challenging, and their role compared to alternative techniques, such as bone transport and Masquelet, remains unclear. This study aims to assess the safety and effectiveness of free fibula flaps in reconstructing critical tibia defects following trauma. Five databases were searched for English-language studies from inception until August 2024. Inclusion criteria involved adult patients undergoing VFFG to the tibia for trauma-induced bone defects. Case reports and studies involving non-traumatic and/or critical bone injury and/or those not undergoing fibula transfer were excluded. Bias was assessed using the ROBINS-I tool. Fifteen studies involving 83 patients with a mean age of 35.07 ± 12.16 (range: 18–65) were included. Ipsilateral fibula transfer was preferred (n = 13, 80%), of and 89.7% fibulas (n = 35) were transferred using a single-barrel approach. The average union rate was 93.08% (95% CI: 86.56, 99.61) across the 74 patients where union outcomes were reported. Flap survival was 100% in seven studies, whilst two studies reported lower survival rates, the lowest being 50%. The overall complication rate was 39.98% (95% CI: 28.25, 51.71), with stress fractures occurring in 35.5% (n = 16) of cases. Revision rates varied from 10 to 40%. The risk of bias was high in 12 studies, and only three studies had a moderate risk. Four studies compared VFFG to alternative management strategies. Vascularised free fibula grafts are effective for reconstructing large segmental tibia defects post-trauma, achieving high union and flap survival rates. However, complication rates are high, and study heterogeneity limits definitive conclusions on the technique's superiority. Further prospective comparative studies are required to characterise the role of VFFG. How to cite this article: Glynou SP, Georgiannakis A, Ardolino D, et al. Vascularised Fibula Transfer for Post-traumatic Critical Tibial Bone Defects: A Systematic Review. Strategies Trauma Limb Reconstr 2025;20(1):37–46.

Closed-loop bioelectronic devices offer a promising platform for responsive treatment to heterogeneous disease states. Glioblastoma, an aggressive form of brain cancer, has recently emerged as a focus of bioelectronic medicine through delivery of electrotherapies. This perspective article posits that true progress in the management of this extremely heterogeneous disease requires the integration of continuous monitoring from the tumor microenvironment as well as on-device analytics to enact closed-loop control. Four promising candidate biological changes present in the glioblastoma microenvironment are highlighted (local field potentials, bioimpedance, local pH, biomarkers) alongside the bioelectronic sensors that can enable the development of multifunctional bioelectronic devices to monitor the changes. Finally, three key principles (patient involvement, data analytics, and device fabrication) governing the successful implementation of closed-loop sensors are proposed to create a roadmap for academics and industry partners to successfully develop multimodal devices for the treatment of glioblastoma.

BRCA genetic testing is available for UK Jewish individuals but the provision of information online for BRCA is unknown. We aimed to evaluate online provision of BRCA information by UK organisations (UKO), UK Jewish community organisations (JCO), and genetic testing providers (GTP). Google searches for organisations offering BRCA information were performed using relevant sets of keywords. The first 100 website links were categorised into UKOs/JCOs/GTPs; additional JCOs were supplemented through community experts. Websites were reviewed using customised questionnaires for BRCA information. Information provision was assessed for five domains: accessibility, scope, depth, accuracy, and quality. These domains were combined to provide a composite score (maximum score = 5). Results were screened (n = 6856) and 45 UKOs, 16 JCOs, and 18 GTPs provided BRCA information. Accessibility was high (84%,66/79). Scope was lacking with 35% (28/79) addressing >50% items. Most (82%, 65/79) described BRCA-associated cancers: breast and/or ovarian cancer was mentioned by 78%(62/79), but only 34% (27/79) mentioned ≥1 pancreatic, prostate, melanoma. Few websites provided carrier frequencies in the general (24%,19/79) and Jewish populations (20%,16/79). Only 15% (12/79) had quality information with some/minimal shortcomings. Overall information provision was low-to-moderate: median scores UKO = 2.1 (IQR = 1), JCO = 1.6 (IQR = 0.9), and GTP = 2.3 (IQR = 1) (maximum-score = 5). There is a scarcity of high-quality BRCA information online. These findings have implications for UK Jewish BRCA programmes and those considering BRCA testing.